Does admission during morning rounds increase the mortality of patients in the medical ICU?

Chest
Magali BisbalLaurent Papazian

Abstract

Early optimization of treatment is crucial when admitting patients to the ICU and could depend on the organization of the medical team. The aim of this retrospective observational study was to determine whether admissions during morning rounds are independently associated with hospital mortality in a medical ICU. The 3,540 patients admitted from May 2000 to April 2010 to the medical ICU of Sainte Marguerite Hospital in Marseille, France, were divided into two groups based on the time of admission.The non-morning rounds group was admitted between 1:00 PM and 7:59 AM , and the morningrounds group was admitted between 8:00 AM and 12:59 PM . Hospital mortality (crude and adjusted)was compared between the two groups. The 583 patients (16.5%) admitted during morning rounds were older and sicker upon admission compared with those patients admitted during non-morning rounds. The crude hospital mortality was 35.2% (95% CI , 31.4-39.1) in the group of patients admitted during morning rounds and 28.0% (95% CI, 26.4-29.7) in the other group ( P < .001). An admission during morning rounds was not independently associated with hospital death (adjusted hazard ratio, 1.10; 95% CI,0.94-1.28; P 5=.24). Being admitted to the medical ICU during mo...Continue Reading

References

Dec 22, 1993·JAMA : the Journal of the American Medical Association·J R Le GallF Saulnier
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Feb 22, 2002·The New England Journal of Medicine·Stephen A BernardKaren Smith
Nov 6, 2003·Intensive Care Medicine·Ari UusaroEsko Ruokonen
Nov 8, 2003·Critical Care Medicine·Jack J LigtenbergJan G Zijlstra
Mar 10, 2004·Intensive Care Medicine·Hannah WunschKathryn Rowan
Mar 16, 2004·Lancet·Werner HackeUNKNOWN NINDS rt-PA Study Group Investigators
Oct 16, 2004·Chest·S Allen EnsmingerBekele Afessa
Aug 16, 2005·Chest·Saqib I Dara, Bekele Afessa
Nov 11, 2005·Critical Care : the Official Journal of the Critical Care Forum·Jean Roger Le GallDaniel Villers
Apr 19, 2007·Critical Care Medicine·Donald B ChalfinUNKNOWN DELAY-ED study group
Aug 25, 2007·Critical Care Medicine·Peter J PronovostLaura L Morlock
Jun 4, 2008·Annals of Internal Medicine·Gordon D Rubenfeld, Derek C Angus
Jun 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Yaseen Arabi
Aug 30, 2008·Journal of Critical Care·Kevin B LauplandH Thomas Stelfox
Apr 8, 2009·Chest·Ognjen Gajic, Bekele Afessa
Jun 9, 2009·Critical Care : the Official Journal of the Critical Care Forum·Iwan A MeynaarPeter E Spronk
Jun 10, 2009·Chest·Bekele AfessaRolf D Hubmayr
Feb 15, 2011·Critical Care Medicine·Ritesh BanerjeeDavid O Meltzer

❮ Previous
Next ❯

Citations

Jul 25, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Michael C McCroryPeter E Morris
Mar 15, 2018·Critical Care : the Official Journal of the Critical Care Forum·Shannon M FernandoKwadwo Kyeremanteng
Feb 26, 2016·Journal of Intensive Care·Krishnaswamy SundararajanCampbell Thompson
Jul 13, 2018·Emergency Medicine Australasia : EMA·Julia CrillyAndrea P Marshall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.